RankingsPricing
  1. JP-listed companies
  2. COSMOS Pharmaceutical Corporation
  3. Financials
  4. Cash from operations

COSMOS Pharmaceutical Corporation【JP:3349】

Market cap
¥611.4B
P/E ratio
19.5x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCash from operations (Million JPY)YoY (%)
May 31, 202552,467-4.91%
May 31, 202455,175+1.36%
May 31, 202354,434+69.08%
May 31, 202232,194+15.49%
May 31, 202127,875-57.42%
May 31, 202065,461+90.41%
May 31, 201934,379+5.50%
May 31, 201832,586-11.78%
May 31, 201736,938+19.21%
May 31, 201630,986+59.28%
May 31, 201519,454-25.07%
May 31, 201425,962

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)